Literature DB >> 22128145

Deletion of HIF-2α in the enterocytes decreases the severity of tissue iron loading in hepcidin knockout mice.

Maria Mastrogiannaki1, Pavle Matak, Stéphanie Delga, Jean-Christophe Deschemin, Sophie Vaulont, Carole Peyssonnaux.   

Abstract

Hereditary hemochromatosis (HH) is a highly prevalent genetic disorder characterized by excessive parenchymal iron accumulation leading to liver cirrhosis, diabetes, and in some cases hepatocellular carcinoma. HH is caused by mutations in the genes encoding upstream regulators of hepcidin or more rarely in the hepcidin gene itself. A deficit in hepcidin results in intestinal iron hyperabsorption; however, the local effectors mediating the up-regulation of iron absorption genes are unknown. We hypothesized that HIF-2 could mediate high iron absorption rates in HH. We generated Hepc(-/-) mice (a murine model of hemochromatosis) lacking HIF-2 in the intestine and showed that duodenal HIF-2 was essential for the up-regulation of genes involved in intestinal iron import and the consequent iron accumulation in the liver and pancreas. This study highlights a role of HIF-2 in the dysregulation of iron absorption and chronic iron accumulation, as observed in patients with hemochromatosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22128145     DOI: 10.1182/blood-2011-09-380337

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Ferroportin-mediated iron transport: expression and regulation.

Authors:  Diane M Ward; Jerry Kaplan
Journal:  Biochim Biophys Acta       Date:  2012-03-13

Review 2.  Regulation of erythropoiesis by hypoxia-inducible factors.

Authors:  Volker H Haase
Journal:  Blood Rev       Date:  2013-01-03       Impact factor: 8.250

Review 3.  The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions.

Authors:  Maria Mastrogiannaki; Pavle Matak; Carole Peyssonnaux
Journal:  Blood       Date:  2013-05-15       Impact factor: 22.113

Review 4.  Therapeutic targeting of the HIF oxygen-sensing pathway: Lessons learned from clinical studies.

Authors:  Volker H Haase
Journal:  Exp Cell Res       Date:  2017-05-05       Impact factor: 3.905

5.  Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia.

Authors:  Erik R Anderson; Matthew Taylor; Xiang Xue; Sadeesh K Ramakrishnan; Angelical Martin; Liwei Xie; Bryce X Bredell; Sara Gardenghi; Stefano Rivella; Yatrik M Shah
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-26       Impact factor: 11.205

6.  Hepatic hepcidin/intestinal HIF-2α axis maintains iron absorption during iron deficiency and overload.

Authors:  Andrew J Schwartz; Nupur K Das; Sadeesh K Ramakrishnan; Chesta Jain; Mladen T Jurkovic; Jun Wu; Elizabeta Nemeth; Samira Lakhal-Littleton; Justin A Colacino; Yatrik M Shah
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 7.  Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  Br J Haematol       Date:  2016-07-21       Impact factor: 6.998

8.  Acute hypoxic exercise does not alter post-exercise iron metabolism in moderately trained endurance athletes.

Authors:  Andrew D Govus; Chris R Abbiss; Laura A Garvican-Lewis; Dorine W Swinkels; Coby M Laarakkers; Christopher J Gore; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2014-07-03       Impact factor: 3.078

9.  Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.

Authors:  Matthew R Pawlus; Liyi Wang; Katie Ware; Cheng-Jun Hu
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

Review 10.  Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.

Authors:  Matthew R Pawlus; Cheng-Jun Hu
Journal:  Cell Signal       Date:  2013-05-21       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.